首页> 美国卫生研究院文献>Innovation in Aging >Linking Epigenetics Metabolism and Cancer: Lessons From SIRT6
【2h】

Linking Epigenetics Metabolism and Cancer: Lessons From SIRT6

机译:链接表观生物学新陈代谢和癌症:SIRT6的课程

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In recent years, chromatin regulators have emerged as key modulators in cancer. We discovered that the mammalian histone deacetylase SIRT6 is a key chromatin factor, modulating expression of metabolic, developmental, and ribosomal protein genes. In recent studies, we identified a loss of function mutation in SIRT6 behind a human syndrome of perinatal lethality. In the context of cancer, we found SIRT6 to act as a robust tumor suppressor, by modulating glucose metabolism. As Otto Warburg described decades ago, cancer cells exhibit glycolytic metabolism, where pyruvate, instead of contributing to ATP production in the mitochondria, is converted to lactate even under normoxia conditions. We found SIRT6 as the first chromatin factor in charge of suppressing the Warburg effect in colon and skin cancer. At the cellular level, SIRT6 inactivation leads to increased cellular glucose uptake, higher lactate production and decreased mitochondrial activity. Our results indicate that SIRT6 directly regulates expression of several key glycolytic and ribosomal genes, co-repressing Hif1a and Myc, respectively, and acting as a histone H3 lysine9 (H3K9) and lysine 56 (H3K56) deacetylase. Notably, we recently identified SIRT6 as the first deacetylase to specifically inhibit transcriptional elongation, rather than initiation, in its targets. Strikingly, we determined in new studies that such glycolytic switch provides an advantage even at the early initiating cancer stem cells stage, in what we identified as the cell-of-origin for the Warburg effect. In addition, we found SIRT6 to act as a robust tumor suppressor in the context of pancreatic cancer. However, in this case, SIRT6 did not influence metabolism, but rather silenced expression of the developmental gene Lin28b, in this way protecting against aggressive undifferentiated pancreatic adenocarcinoma. Our studies highlight the important role epigenetic factors, such as SIRT6, play in protecting against tumor progression by providing “epigenetic plasticity”, inhibiting adaptive responses in transformed cells.
机译:近年来,染色质调节剂已成为癌症中的主要调节剂。我们发现哺乳动物组蛋白脱乙酰化酶SIRT6是染色质因子,调节代谢,发育和核糖体蛋白基因的表达。在最近的研究中,我们确定了SIRT6在围产期杀伤性的人类综合征背后的功能突变丧失。在癌症的背景下,我们发现SIRT6通过调节葡萄糖代谢来充当强大的肿瘤抑制剂。作为几十年前描述的奥托沃堡,癌细胞表现出糖酵解代谢,其中丙酮酸,而不是促进线粒体中的ATP产量,即使在常氧化条件下也转化为乳酸乳酸盐。我们发现SIRT6作为第一种负责抑制结肠和皮肤癌的Warburg作用的第一种染色质因子。在细胞水平,SIRT6灭活导致细胞葡萄糖摄取,较高的乳酸盐产生和线粒体活性降低。我们的结果表明,SIRT6分别直接调节几种关键糖酵母和核糖体基因,共抑制HIF1A和MYC的表达,并用作组蛋白H3赖氨酸9(H3K9)和赖氨酸56(H3K56)脱乙酰酶。值得注意的是,我们最近将SIRT6鉴定为首先脱乙酰化酶,以特异性抑制其靶标的转录伸长率而不是引发。令人惊讶的是,我们在新的研究中确定了这种糖酵解开关即使在早期发起癌症干细胞阶段提供了优势,我们认为我们被识别为Warburg效应的原产地。此外,我们发现SIRT6在胰腺癌的背景下充当强大的肿瘤抑制剂。然而,在这种情况下,SIRT6不影响代谢,而是沉默的发育基因LIN28B的表达,以这种方式保护侵袭性未分化的胰腺腺癌。我们的研究强调了通过提供“表观遗传塑性”,抑制转化细胞中的适应性反应来保护患者6,如SIRT6,如SIRT6的重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号